Why Arcosa, Inc. (ACA) stock moved
Arcosa, Inc. (ACA) shares rose 0.0% to $145.01 as of July 20, 2026, a slight gain from the prior close of $145.00. BestStocks flagged the session as a major change for ACA. The move is tied to a new SEC filing. Below, we break down what changed for ACA, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
SEC Filing
Arcosa, Inc. (ACA) filed an 8-K on July 15, 2026. The evidence provides only the filing date and does not disclose the specific content or nature of the disclosure. Review the full 8-K filing text once available to identify the disclosed event and its potential impact.
What it means for Arcosa, Inc. investors
For Arcosa, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.0% session move; ACA moved +0.44% from $144.75 to $145.38 on 2026-07-08. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $140.00, implying -3.5% downside from $145.01. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 17 days out, the next report is the most likely near-term test of the move.
ACA price reaction
ACA last traded at $145.01, up $0.01 (+0.01%) from the previous close of $145.00. The session traded on 1.6× average volume (above avg), so the move carried above-average conviction. Over the past month the stock has ranged between $144.34 and $145.38, and it currently sits about 64% of the way up that band.
Bullish and bearish analyst opinions on Arcosa, Inc. (ACA)
The consensus analyst price target on Arcosa, Inc. (ACA) is $140.00, 3.5% below the recent $145.01. Over the past 90 days analysts logged 0 upgrades, 1 maintain, and 0 downgrades. Here is how the bullish and bearish cases on ACA line up.
The bullish case
- Positive 0.0% session move.
- ACA moved +0.44% from $144.75 to $145.38 on 2026-07-08.
- ACA moved +0.28% from $144.97 to $145.38 on 2026-07-06.
- Arcosa, Inc. (ACA) moved +0.15% from $145.29 to $145.50 on 2026-07-01, reaching a new 30-day high.
The bearish case
- The consensus analyst price target of $140.00 sits 3.5% below the recent $145.01, so the average target sees limited room to run.
- The most bearish analyst target is $140.00 (-3.5%).
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 20, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for ACA
Frequently asked questions about ACA
Why did Arcosa, Inc. (ACA) stock move?
ACA rose 0.0% to $145.01. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did ACA stock rise?
ACA gained 0.01% ($0.01) versus the prior close of $145.00, last trading at $145.01 on 1.6× average volume.
When is Arcosa, Inc.'s next earnings date?
ACA's next earnings report is estimated for 2026-08-06 — about 17 days away.
What is the analyst price target for ACA?
The consensus analyst price target for ACA is $140.00, about 3.5% below the current $145.01. Over the past 90 days, analysts recorded 0 upgrades, 1 maintain, and 0 downgrades.
How BestStocks tracks ACA
This page is generated automatically by BestStocks' change-detection system after a new SEC filing was detected and verified against independent data sources. It draws on 6 tracked change events for ACA, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 20, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.